date,title,source
Oct-24-18,OncoSec Announces Publication of Data in Nature Gene Therapy Demonstrating the Ability of its Newly Optimized Intratumoral IL-12 Immunotherapy Platform to Increase Systemic Anti-tumor Responses in both Treated and Untreated Lesions,PR Newswire
Oct-29-18,OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer,PR Newswire
Nov-05-18,OncoSec to Host Conference Call to Review Preliminary KEYNOTE-695 Data,PR Newswire
